If You Invested $25,000 in Abbott Laboratories in 2013, This Is How Much You Would Have Today
It has been more than nine years since Abbott Laboratories (NYSE: ABT) spun off AbbVie (NYSE: ABBV). By doing so, AbbVie could focus on research and developing breakthrough therapies while Abbott could remain a diversified healthcare company focused on generic pharmaceuticals, medical devices, diagnostics, and nutrition.
The move has worked out well for AbbVie, which today has a larger market capitalization than Abbott's. But how has it worked out for Abbott, and would its investors have made the right move if they bought $25,000 worth of shares in the company back then?
In the years since the deal, Abbott has more than doubled its annual revenue, and COVID-19 testing played a big role:
Source Fool.com
